BCAMX
Price
$80.27
Change
-$0.76 (-0.94%)
Updated
Jul 13 closing price
Net Assets
79.59M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

BCAMX vs VSTSX

BCAMX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
BCAMX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAMX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. BCAMX (79.6M). VSTSX pays higher dividends than BCAMX: VSTSX (1.07) vs BCAMX (0.03). BCAMX was incepted earlier than VSTSX: BCAMX (14 years) vs VSTSX (10 years). BCAMX (1.12) is less costly to investors than VSTSX (0.01). BCAMX is a more actively managed with annual turnover of: 25.00 vs. VSTSX (3.00). BCAMX has a lower initial minimum investment than VSTSX: BCAMX (10000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. BCAMX (11.02). VSTSX return over 5 years is better than : 66.56 vs. BCAMX (30.12).
BCAMXVSTSXBCAMX / VSTSX
Total Expense Ratio1.000.0110,000%
Annual Report Gross Expense Ratio1.120.0111,200%
Fund Existence14 years10 years-
Gain YTD8.34311.20574%
Front LoadN/AN/A-
Min. Initial Investment1000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets79.6M2.3T0%
Annual Yield % from dividends0.031.073%
Returns for 1 year11.0221.4851%
Returns for 3 years44.8367.0667%
Returns for 5 years30.1266.5645%
Returns for 10 years129.03239.5354%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I